Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 3

Sponsor Class

NIH 60OTHER 28UNKNOWN 3OTHER_GOV 2NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Breast Neoplasms 1

Interventions

Capecitabine 15Paclitaxel 13S 1 (combination) 9apatinib 8Oxaliplatin 8Carboplatin 8Cisplatin 7pyrotinib 6Epirubicin 6Docetaxel 6sintilimab 5camrelizumab 5anlotinib 5Radiotherapy 5Drug Therapy 5130-nm albumin-bound paclitaxel 5nimotuzumab 4nedaplatin 4Vinorelbine 4Temozolomide 4Irinotecan 4Fulvestrant 4Etoposide 4Bevacizumab 4toripalimab 3titanium silicide 3exemestane 3Trastuzumab 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Chemotherapy, Adjuvant × Clear all
NCT04664504 2021-06-08

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

ChineseAMS

Phase 2 Unknown
150 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

ChineseAMS

Phase 2 Unknown
230 enrolled
Breast

Breast Neoplasms

NCT02648841 2016-01-07

A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

ChineseAMS

Phase 3 Unknown
588 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡